Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (401) clinical trials

The purpose of the study is to determine if a study medication helps patients with chronic obstructive pulmonary disease (COPD) with emphysema. There will be 7 study visits. Visits will take about 2 hours. There will be a physical exam, vital signs, urine test, blood draw, breathing tests, questionnaires, and ...

Phase N/A

24 week study to assess the efficacy and safety of Glycopyrronium/Formoterol Fumarate (GFF) fixed-dose combination 7.2/4.8 µg 2 inhalations twice daily compared to Umeclidinium/Vilanterol (UV) 62.5/25 µg fixed-dose combination 1 inhalation once daily in patients 40-95 years of age, with moderate to very severe COPD.

Phase N/A

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

COPD-chronic obstructive pulmonary disease

Phase N/A

Clinical research trial for people with moderate to severe COPD (Chronic Pulmonary Disease)

Phase N/A

An observational study on patients with a diagnosis or suspected diagnosis of asthma and/or COPD to describe patient characteristics, treatment patterns and the burden of illness over time.

Phase N/A

Do you suffer from stiff, sore, aching joints and have been diagnosed with Rheumatoid Arthritis? If so, Clinical Research of West Florida is currently enrolling for an investigational medication for Rheumatoid Arthritis. If your Rheumatoid Arthritis is active and you are receiving Methotrexate, you may qualify to take part in ...

Phase N/A

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview Study Flyer

Phase N/A

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview

Phase N/A

If you are a current or former smoker living with COPD, which includes chronic bronchitis and emphysema, you may qualify for this clinical research study.

Phase N/A